Fri, Aug 29, 2014, 2:47 AM EDT - U.S. Markets open in 6 hrs 43 mins

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • bridgelight bridgelight Mar 4, 2013 5:25 AM Flag

    BLFS – the most advanced company for biopreservation media products!

    Zacks small-cap research - Demand for biopreservation media is estimated to grow at an
    annual rate of almost 20% over the next several years,
    largely driven by rapid growth of the emerging field of
    regenerative medicine (including cell therapy and tissue
    engineering, according to MedMarket Diligence . Another study, from Visiongain, also supports a robust outlook for regenerative medicine and predicts this market
    will grow from $1.4 billion in 2012 to $10 billion in 2020 (~28% CAGR).
    BioLife expects to benefit from the emerging field of regenerative medicine and is positioning their HypoThermosol and CryoStor products as a better
    alternative to other branded biopreservation media and home-brews.

    Sentiment: Buy

 
CLDX
15.74-0.41(-2.54%)Aug 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.